Table 1.

Summary of clinical and biological data of the population studied

	Non-responsive population (n = 153)	Participating population (n = 55)	p value
Epidemiological data
Age (years)	36 [16–88]	46 [17–76]	0.087
SAPS II	27 [6–65]	26 [7–66]	0.93
ISS	18 [9–41]	18 [9–41]	0.42
Gender ratio (Male/female)	114 (74.5%)/39 (25.5%)	43 (78.2%)/12 (21.8%)	0.59
Biological data
pH	7.5 [7.02–7.99]	7.35 [7.19–7.5]	0.36
Serum lactate (mmol/l)	1.9 [0.55–12.9]	1.8 [0.4–9.85]	0.99
Hemoglobin (g/dl)	12.1 [4.5–16.89]	11.6 [7.5–16.8]	0.81
Injury data (n, %)
Thorax	111 (72.5%)	38 (69.1%)	0.63
Skull	71 (46.4%)	31 (56.4%)	0.21
Limbs	78 (51%)	29 (52.7%)	0.83
Abdomen	46 (30.1%)	22 (40%)	0.18
Spine	43 (28.1%)	17 (30.9%)	0.70
Pelvis	41 (26.8%)	15 (27.3%)	0.95
Face	41 (26.8%)	12 (21.8%)	0.47
Therapeutics
Transfusion	93 (61.2%)	36 (66.7%)	0.48
Emergency surgery	70 (47.3%)	29 (52.7%)	0.49
Length of mechanical ventilation (days)	1 [0–52]	1 [0–43]	0.33
Length of hospitalization in the ICU (days)	12 [1–93]	13 [3–63]	0.96
Length of overall hospitalization (days)	25 [2–123]	25 [3–108]	0.57

Results expressed in median and extreme values as well as numeric values and averages (%). SAPS II: Simplified Acute Physiology Score II, ISS: Injury Severity Score